![Herve Hoppenot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Herve Hoppenot
Direktor/Vorstandsmitglied bei
BICYCLE THERAPEUTICS PLC
Vermögen: 10 Mio $ am 31.08.2026
Profil
Herve Hoppenot bekleidet die Position des Chairman, President & Chief Executive Officer der Incyte Corp. Er ist außerdem Mitglied des Vorstands der Biotechnology Innovation Organization, der Cellectis SA und der Pharmaceutical Research & Manufacturers of America. In seiner früheren Laufbahn war er Präsident bei Novartis Oncology, Inc. und Präsident bei Novartis Pharmaceuticals Corp. sowie Leiter des Geschäftsbereichs Onkologie in den USA bei Aventis SA, Vizepräsident des Geschäftsbereichs Onkologie bei Aventis Pharmaceuticals, Inc. und Leiter des Geschäftsbereichs Onkologie bei Rhone-Poulenc Rorer Pharmaceuticals, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INCYTE CORPORATION 0.04% | 14.04.2026 | 83’411 ( 0.04% ) | 10 Mio $ | 31.08.2026 |
| 13.04.2026 | 13’258 ( 0.03% ) | 54 756 $ | 31.08.2026 | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 08.06.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktive Positionen von Herve Hoppenot
| Unternehmen | Position | Beginn |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 08.09.2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
npower
 npower Miscellaneous Commercial ServicesCommercial Services Provides technological assistance to nonprofit organizations | Direktor/Vorstandsmitglied | 01.11.2021 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Vorsitzender | 06.10.2025 |
Ehemalige bekannte Positionen von Herve Hoppenot
| Unternehmen | Position | Ende |
|---|---|---|
| INCYTE CORPORATION | Vorstandsvorsitzender | 26.06.2025 |
| CELLECTIS S.A. | Direktor/Vorstandsmitglied | 27.06.2023 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Präsident | 01.01.2014 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Präsident | 01.01.2014 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Herve Hoppenot
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Rhone Poulenc AG, Inc.
 Rhone Poulenc AG, Inc. Chemicals: SpecialtyProcess Industries Manufactures pharmaceuticals and chemicals | Process Industries |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
npower
npower Miscellaneous Commercial ServicesCommercial Services Provides technological assistance to nonprofit organizations | Commercial Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
